Programmable Biology: AI, Synthetic DNA, and the Future of Therapeutic Discovery

​Join an exclusive gathering of leaders across biotechnology, synthetic biology, artificial intelligence, and venture capital to explore how advances in synthetic DNA, AI-enabled discovery, and next-generation biotech platforms are transforming therapeutic development and accelerating innovation across the life sciences ecosystem.

​The evening will feature a moderated 60-minute panel discussion with distinguished founders, researchers, investors, and operators, followed by a networking reception designed to foster meaningful connections among innovators shaping the future of biotechnology.

​Discussion topics may include AI-driven drug discovery, scalable synthetic DNA technologies, biotech infrastructure and commercialization, translational medicine, and the opportunities and challenges of building next-generation life sciences companies at the intersection of science, technology, and entrepreneurship.

​Whether you're a founder, scientist, investor, operator, or emerging biotech professional, this event offers a unique opportunity to engage with leading voices driving the future of healthcare and biotechnology.

​Proudly sponsored by Bakar Bio Labs.

​Meet the Host

​Berkeley Pharma Tech Foundation is a nonprofit committed to expanding biotech understanding and improving access to the industry through education, mentorship, and networking. We host roundtables, speaker panels, and community events to connect aspiring scientists and entrepreneurs with industry leaders. Our goals: launch a funded research program within two years and build a state-of-the-art lab in the Bay Area within five. Follow us on LinkedIn or reach out to Vanloan Nguyen to get involved!